EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting the Notch1‐YY1‐ICAM1 Signaling Axis Enhances the Efficacy of Immunotherapy in HCC by Activating CD8 + T‐Cell‐Driven Cancer Cell Pyroptosis

Ke Zhu, Fa-Peng Zhang, Chao Qin, Zhi-Xiao Song, Cai-Ni Yang, Shu-Sheng Lin, Xian-Huan Yu, Wen-Rui Wu, Chao-Qun Liu, Chao Liu, Lei-Bo Xu

Advanced Science · 2026

DOI: 10.1002/advs.202512845 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Ke Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Key Laboratory of Precise Diagnosis and Treatment of Biliary Tract Cancer, Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial H…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, CD8-Positive T-Lymphocytes, Receptor, Notch1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangzhou Key Laboratory of Organ Transplantation, Major Clinical Technology Program of Guangzhou Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has shown a modest clinical benefit in advanced hepatocellular carcinoma (HCC), probably due to tumor immunosuppressive functions. Although Notch1 signaling has been implicated in tumor immune escape, its underlying mechanism is unclear. Here, Notch1 signaling is established as a determinant of immunotherapy efficacy in HCC. Studies showed that high Notch1 expression correlates with poor progression‐free survival and worse immunotherapeutic response in recurrent HCC patients, while Notch1 overexpression promotes cancer cell escape by inhibiting CD8 + T cell activation. Mechanistically, Notch1 overexpression upregulates the expression of transcriptional factor YY1 (Yin‐Yang 1), which in turn represses ICAM1 expression to prohibit CD8 + T cell‐derived granzyme‐driven cancer cell pyroptosis and cytotoxicity. Finally, co‐administration of a PD‐L1 antibody with PEI‐siYY1 represses HCC tumor growth without causing severe adverse effects, as observed with the Notch1 inhibitor DAPT. The results establish that targeting Notch1‐YY1‐ICAM1 signaling axis may enhance immunotherapy efficacy by activating CD8 + T cell‐driven cancer cell pyroptosis, providing a safe and effective treatment strategy for HCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsCD8-Positive T-LymphocytesReceptor, Notch1PyroptosisImmunotherapyIntercellular Adhesion Molecule-1YY1 Transcription FactorHumansSignal TransductionMiceAnimalsCell Line, TumorMaleFemale

Stichwörter der Autor:innen

Notch1YY1hepatocellular carcinomaspyroptosistumor‐specific CD8+ T cells

Substanzen

Receptor, Notch1NOTCH1 protein, humanIntercellular Adhesion Molecule-1YY1 Transcription FactorYY1 protein, humanICAM1 protein, human

Autor:innen und Institutionen

  • Guangzhou Key Laboratory of Precise Diagnosis and Treatment of Biliary Tract Cancer, Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, Ch…
  • Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518000, China.
  • Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.

Förderung

  • National Natural Science Foundation of China
  • Guangzhou Key Laboratory of Organ Transplantation
  • Major Clinical Technology Program of Guangzhou Municipal Health Commission
  • Sun Yat-Sen University Clinical Research 5010 Program
  • Sun Yat-Sen Memorial Hospital Clinical Research 5010 Program
  • Sun Yat-sen Pilot Scientific Research Fund
  • Guangdong Provincial Medical Science and Technology Research Foundation

Zitieren

APA

Zhu, K., Zhang, F. P., Qin, C., Song, Z. X., Yang, C. N., Lin, S. S., Yu, X. H., Wu, W. R., Liu, C. Q., Liu, C., & Xu, L. B. (2026). Targeting the Notch1‐YY1‐ICAM1 Signaling Axis Enhances the Efficacy of Immunotherapy in HCC by Activating CD8 + T‐Cell‐Driven Cancer Cell Pyroptosis. Advanced Science. https://doi.org/10.1002/advs.202512845

Vancouver

Zhu K, Zhang FP, Qin C, Song ZX, Yang CN, Lin SS, et al. Targeting the Notch1‐YY1‐ICAM1 Signaling Axis Enhances the Efficacy of Immunotherapy in HCC by Activating CD8 + T‐Cell‐Driven Cancer Cell Pyroptosis. Advanced Science. 2026. doi:10.1002/advs.202512845

BibTeX
@article{Zhu2026,
  author = {Zhu, Ke and Zhang, Fa-Peng and Qin, Chao and Song, Zhi-Xiao and Yang, Cai-Ni and Lin, Shu-Sheng and Yu, Xian-Huan and Wu, Wen-Rui and Liu, Chao-Qun and Liu, Chao and Xu, Lei-Bo},
  title = {Targeting the Notch1‐YY1‐ICAM1 Signaling Axis Enhances the Efficacy of Immunotherapy in HCC by Activating CD8 + T‐Cell‐Driven Cancer Cell Pyroptosis},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202512845}
}
Kostenlos starten →